Balance Sheet
Accounts PayablesAccumulated DepreciationAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pulse Biosciences (PLSE) Other Accumulated Expenses (2020 - 2025)

Pulse Biosciences (PLSE) has 6 years of Other Accumulated Expenses data on record, last reported at $363000.0 in Q4 2025.

  • For Q4 2025, Other Accumulated Expenses rose 93.09% year-over-year to $363000.0; the TTM value through Dec 2025 reached $363000.0, up 93.09%, while the annual FY2025 figure was $363000.0, 93.09% up from the prior year.
  • Other Accumulated Expenses reached $363000.0 in Q4 2025 per PLSE's latest filing, up from $351000.0 in the prior quarter.
  • Across five years, Other Accumulated Expenses topped out at $513000.0 in Q4 2021 and bottomed at $167000.0 in Q2 2024.
  • Average Other Accumulated Expenses over 5 years is $277642.9, with a median of $262500.0 recorded in 2021.
  • The widest YoY moves for Other Accumulated Expenses: up 112.93% in 2021, down 67.18% in 2021.
  • A 5-year view of Other Accumulated Expenses shows it stood at $513000.0 in 2021, then crashed by 58.09% to $215000.0 in 2022, then dropped by 20.0% to $172000.0 in 2023, then increased by 9.3% to $188000.0 in 2024, then skyrocketed by 93.09% to $363000.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Other Accumulated Expenses were $363000.0 in Q4 2025, $351000.0 in Q3 2025, and $188000.0 in Q4 2024.